SBIR/STTR Research Award
A New Class of Non-Opioid Analgesics for Use in Chronic Pain Management
Award amount
$999,830Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- Kalyra Pharmaceuticals, Inc.
- Proposal award date
- 2017-09-25
- Contract end date
- 2019-02-24
- UEI
- JW3AWK3ATUE9
- Solicitation number
- 2017.0
- Topic code
- Non-DOD
Research abstract
There has been considerable interest in the development of alternative therapies for pain management that are neither opioid nor non-steroidal anti-inflammatory drugs (NSAIDs). Kalyra Pharmaceuticals has demonstrated that acetaminophen, also known as APAP
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel MAP Kinase Pathway Inhibitors to Treat Pancreatic Ductal AdenoCarcinoma
- A New Treatment to Reduce Scarring
- A new class of non opioid analgesics for use in chronic pain management
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Low-Cost MCM Sound Velocity Profiler Based on MASED
- Development of an Integrated Tip Timing/ Radar Probe System
- Manufacture of Monolithic Telescope with a Freeform Surface
- 3D Printed Ceramic Matrix Composites for Hypersonics
- Innoflight Middleware System (IMS)
Research funding history
4 SBIR/STTR records share this UEI (2015–2017). Reported award amounts total $4,073,230. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense